Here's Why Athersys Stock Is Soaring Today
Shares of Athersys (NASDAQ: ATHX) rose over 29% today after Bank of America (BofA) Securities initiated coverage of the stem cell specialist with a buy rating and a $5 price target.
Considering the stock remains under $3 per share even after today's jump, that implies significant upside if the bullishness of BofA Securities proves correct. However, individual investors can't overlook one big conflict of interest.
As of 1:03 p.m. EDT, the small-cap stock had settled to a 27.7% gain.
Source Fool.com
